1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019) Authors: Heerspink, Hiddo J L; Parving, Hans-Henrik; Andress, Dennis L; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Melnick, Joel Z; Miller, Michael G; Pergola, Pablo E; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderso... Journal: Lancet Issue: Volume 393:Issue 10184(2019) Page Start: 1937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea. Issue 11 (22nd November 2020) Authors: You, Ji Hong; Song, Sun Ok; Kang, Min Jin; Cho, Yoon Young; Kim, Sun Wook; Suh, Sung Hwan; Lee, Sujin; Lee, Yong-ho; Lee, Byung-Wan Journal: Clinical and translational gastroenterology Issue: Volume 11:Issue 11(2020) Page Start: e00254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗